P. Curatolo Et Al. , "Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial," LANCET CHILD & ADOLESCENT HEALTH , vol.2, no.7, pp.495-504, 2018
Curatolo, P. Et Al. 2018. Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial. LANCET CHILD & ADOLESCENT HEALTH , vol.2, no.7 , 495-504.
Curatolo, P., Franz, D. N., Lawson, J. A., Yapici, Z., Ikeda, H., Polster, T., ... Nabbout, R.(2018). Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial. LANCET CHILD & ADOLESCENT HEALTH , vol.2, no.7, 495-504.
Curatolo, Paolo Et Al. "Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial," LANCET CHILD & ADOLESCENT HEALTH , vol.2, no.7, 495-504, 2018
Curatolo, Paolo Et Al. "Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial." LANCET CHILD & ADOLESCENT HEALTH , vol.2, no.7, pp.495-504, 2018
Curatolo, P. Et Al. (2018) . "Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial." LANCET CHILD & ADOLESCENT HEALTH , vol.2, no.7, pp.495-504.
@article{article, author={Paolo Curatolo Et Al. }, title={Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial}, journal={LANCET CHILD & ADOLESCENT HEALTH}, year=2018, pages={495-504} }